Healthcare ❯Pharmaceuticals ❯Weight Loss Drugs

Zepbound

Eli Lilly Sales Projections FDA Approval Mounjaro

Weight-Loss Drug Tirzepatide Shows Promise for Treating Sleep Apnea

New study reveals significant reduction in sleep apnea symptoms and potential decrease in CPAP machine dependency.

Eli Lilly's Q1 Earnings Surge on Strong Zepbound and Mounjaro Sales

Eli Lilly and Amazon Partner to Deliver Weight Loss Drug Zepbound Directly to Consumers